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Laboratory workflows and preclinical models have become increasingly diverse and
complex. Confronted with the dilemma of a multitude of information with ambiguous
relevance for their specific experiments, scientists run the risk of overlooking critical
factors that can influence the planning, conduct and results of studies and that should
have been considered a priori. To address this problem, we developed “PEERS”
(Platform for the Exchange of Experimental Research Standards), an open-access online
platform that is built to aid scientists in determining which experimental factors and
variables are most likely to affect the outcome of a specific test, model or assay and
therefore ought to be considered during the design, execution and reporting stages.
The PEERS database is categorized into in vivo and in vitro experiments and provides
lists of factors derived from scientific literature that have been deemed critical for
experimentation. The platform is based on a structured and transparent system for
rating the strength of evidence related to each identified factor and its relevance for a
specific method/model. In this context, the rating procedure will not solely be limited
to the PEERS working group but will also allow for a community-based grading of
evidence. We here describe a working prototype using the Open Field paradigm in
rodents and present the selection of factors specific to each experimental setup and
the rating system. PEERS not only offers users the possibility to search for information
to facilitate experimental rigor, but also draws on the engagement of the scientific
community to actively expand the information contained within the platform. Collectively,
by helping scientists search for specific factors relevant to their experiments, and
to share experimental knowledge in a standardized manner, PEERS will serve as a
collaborative exchange and analysis tool to enhance data validity and robustness as well
as the reproducibility of preclinical research. PEERS offers a vetted, independent tool by
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which to judge the quality of information available on a certain test or model, identifies
knowledge gaps and provides guidance on the key methodological considerations that
should be prioritized to ensure that preclinical research is conducted to the highest
standards and best practice.
Keywords: reproducibility, study design, neuroscience, transparency, quality rating, animal models, study
outcome, platform
INTRODUCTION AND RATIONALE
Biomedical research, particularly in the preclinical sphere, has
been subject to scrutiny for the low levels of reproducibility
that continue to persist across laboratories (Ioannidis, 2005).
Reproducibility in this context refers to the ability to corroborate
results of a previous study by conducting new experiments
with the same experimental design but collecting new and
independent data sets. Reproducibility checks are common
in fields like physics (CERN, 2018), but rarer in biological
disciplines such as neuroscience and pharmacotherapy, which
are increasingly facing a “reproducibility crisis” (Bespalov et al.,
2016; Bespalov and Steckler, 2018; Botvinik-Nezer et al., 2020).
Even though a high risk of failure to repeat experiments
between laboratories is an inherent part of developing innovative
therapies, some risks can be greatly reduced and avoided by
adherence to evidence-based research practices using clearly
identified measures to improve research rigor (Vollert et al.,
2020; Bespalov et al., 2021; Emmerich et al., 2021). Alternative
initiatives have been introduced to increase data reporting
and harmonization across laboratories [ARRIVE 2.0 (Percie
du Sert et al., 2020); EQUATOR network (Simera, 2008);
The International Brain Laboratory (The International Brain
Laboratory, 2017); FAIRsharing Information Resource (Sansone
et al., 2019)], improve data management and analysis [Pistoia
Alliance Database (Makarov et al., 2021); NINDS Common
Data Elements (Stone, 2010); FITBIR: Traumatic Brain Injury
network (Tosetti et al., 2013); FITBIR: Preclinical Traumatic
Brain Injury Common Data Elements (LaPlaca et al., 2021)],
or publish novel methods and their refinements (Norecopa;
Current Protocols in Neuroscience; protocols.io; The Journal of
Neuroscience Methods). However, extrinsic and intrinsic factors
that affect study outcomes in biomedical research have not yet
been systematically considered or weighted and are the subject of
“PEERS” (Platform for the Exchange of Experimental Research
Standards). This makes PEERS a unique addition to this eclectic
list of well-established resources.
The rationale for PEERS is as follows: Laboratory workflows
and preclinical models have become increasingly diverse and
complex. Although the mechanics of many experimental
paradigms are well explored and usually repeatable across
laboratories and even across national/continental boundaries
(Robinson et al., 2018; Aguillon-Rodriguez et al., 2021), data can
be highly variable and are often inconsistent. Multiple attempts
have been made to overcome this issue, but even efforts in
which experimental conditions were fully standardized between
laboratories have not been completely successful. This may
not be surprising given that behavioral testing, for example, is
sensitive to environmental factors such as housing conditions
(background noise, olfactory cues), experimenter interactions,
and the sex or strain of the animal under investigation (Sousa
et al., 2006; Bohlen et al., 2014; Riedel et al., 2018; Pawluski
et al., 2020; Butlen-Ducuing et al., 2021). Many multi-laboratory
studies have also observed significant differences between mouse
strains and interactions of genotype ∗ laboratory despite efforts to
rigorously standardize both housing conditions and experimental
design (Wolfer et al., 2004; Richter et al., 2011). Taking together,
there are many variables/factors that can affect an experiment and
the outcome of a study.
A proper catalog of these influencing factors, including the
scientific evidence combined with a rating of its strength, is
missing to date. PEERS seeks to fill this gap and aims to
guide scientists by advising which factors need to be monitored,
recorded or reported. Figure 1 represents the overarching
concept of the PEERS platform.
THE PEERS SOLUTION
To mitigate some of the above issues, we have developed PEERS,
an open-access online platform that seeks to aid scientists in
determining which experimental factors (or variables) most
likely affect the outcome of a specific test, model or assay and
therefore deserve consideration prior to study design, execution
and reporting. Our overarching ambition is to develop PEERS
into a one-stop exchange and reporting tool for extrinsic and
intrinsic factors underlying variability in study outcomes and
thereby undermining scientific progress. At the same time,
PEERS offers a vetted, independent perspective by which the
quality of information available on a certain test or model can be
judged. It will also identify knowledge gaps and provide guidance
on key methodological considerations that should be prioritized
to ensure that preclinical research is conducted to the highest
standards and incorporates best practice.
The PEERS Consortium
The PEERS project can be traced back to the Global
Preclinical Data Forum (GPDF),1 a network financially
and organizationally supported by the European College
of Neuropsychopharmacology (ECNP; PMID: 26073278,
doi: 10.1016/j.euroneuro.2015.05.011) and Cohen Veterans
Bioscience (CVB). The GPDF focuses on robustness,
reproducibility, translatability and transparency of reporting
preclinical data and consists of a multinational consortium of
1https://www.preclinicaldataforum.org/
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FIGURE 1 | Outline of the PEERS concept and workflow (the 3Es). To
understand whether specific factors are relevant for certain methods/models
(“protocols”), the PEERS workflow is based on different steps to collect
information about selected factors/protocols from publications or the scientific
community (“Evidence”); rate the strength of this information and provide
mechanisms for editing, curating and maintaining the information/database
(“Evaluation”); and present the outcome in a user-friendly and digestible form
(“Extraction Output”) so that users will be provided with an answer helpful
for their planned experiments.
specialist researchers from research institutions, universities,
pharma companies, “small medium entities” and publishers.
Originating from the GPDF, the PEERS Working Group (authors
AS, CD, CF-B, AH, KK, MK, NK, KP, GR, CE) is currently funded
by CVB during its initiation phase. The Working Group consists
broadly of a “scientific arm” with long-standing expertise in
neuroscience, reproducibility and improvements in data quality
across academic and industrial preclinical biomedical research.
The “scientific arm” of the group is complemented by the strong
software and machine learning expertise of the “software arm”
which translates the scientific input provided into an easy to
navigate open access online platform.
Therefore, our initial focus is on in vivo and in vitro
methods commonly utilized in neuroscience research. Since the
inaugural meeting on 10 September 2020, the implementation of
a principal concept was agreed, and partners have contributed to
different work-packages.
How Does PEERS Work?
The PEERS Database and Its Front and Back-End
Functionalities
Figure 2 represents the overall structure of the platform with
the front and back-end functionalities represented. The front
end contains a data input module which allows registered users
to add either new methods/models (here termed “protocols”)
or provide add-on information to existing protocols, but also
the data search and the data extraction modules to be used
by a typical user for the examination of databases and the
retrieval of information. The back end of the PEERS database
contains the processes to collect and analyze information related
to the selected protocols. The relevance of specific factors for the
outcome of these protocols is analyzed based on a detailed scoring
system, representing a central element of the PEERS working
prototype. The different steps involved in setting up this platform
are discussed in the sections below by following the 3Es identified
in Figure 1.
Selection of in vivo/in vitro Protocols
For the working prototype and as a proof-of-concept, four in vivo
and four in vitro protocols were identified (see Table 1), based
on (1) how commonly they are used in neuroscience (and by
extension the literature available on them), and (2) the expertise
of the core group.
Selection of “Factors”
The central elements of PEERS are called “factors,” defined as
any aspect of a study that can affect the study outcome. Thus,
information how to incorporate them into the study design (e.g.,
ignore/control, monitor, report them) is required. Factors were
divided into two categories by utilizing expert opinion from
within the PEERS consortium: (1) generic factors relevant to all
protocols (e.g., strain of animals) and (2) specific factors relevant
to and affecting specific protocols only (e.g., water temperature
for water maze). Users of the platform can search for these factors
depending on the protocols and outcomes they are interested
in. Representative tables of factors for one in vivo (Open Field)
and one in vitro method (Western blotting) can be found in the
Supplementary Tables 1, 2.
Collection of References That Report on Selected “Factors” –
The Evidence
To identify and collate references that study the importance of
a specific factor for a selected protocol and its outcome, an
extensive review of published literature via the PubMed and
EMBASE databases was conducted. These included references
dealing with either a factor of interest that had an effect on the
protocol outcome or one that had no effect on the outcome
when manipulated. A representative table of factors and the
associated references for the Open Field protocol are provided in
the Supplementary Table 1.
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FIGURE 2 | PEERS platform structure. Users can interact with the PEERS platform (blue arrows) by searching for or adding information (Front End Modules). The
PEERS database (Back End) consists of various protocols, for which generic and specific factors and related references have been identified. The Quality of
Evidence for the importance of certain factors is evaluated using scorecards and a summary is presented by visualizing results in the user interface. Users can
contribute by adding new protocols or factors and by scoring relevant references (green arrows).
Grading of Evidence: Description of Structured
Approach
Within the PEERS database, we provide references for each
factor that has been scrutinized. We have gone one step further
by providing a grading of the strength of this evidence so
that examination of a specific factor in the database provides
the user with an extracted summary of all relevant papers
and their scores from one or more assessors (scorecards). This
required the development of a generic “checklist” to determine
the quality of each paper the details of which are described in the
following section.
Checklist for Grading of Evidence/Publications - The
Evaluation
Concurrent with the identification of experimental factors and
the review of literature, novel detailed “scorecards” to evaluate
the quality of scientific evidence were refined through multiple
Delphi rounds within the PEERS Working Group. These
scorecards contain a checklist with two main domains: Methods
and Results. The elements of these domains were determined
based on ARRIVE 2.0 “Essential 10” and recommendations of
the EQIPD consortium (Percie du Sert et al., 2020; Vollert et al.,
2020). The Methods domain assesses the adherence to these
guidelines with a maximum score of 10 (essentially one point for
each of the 10 items – or fractions of 1 if items are only covered
partially - or zero points if specific items are not covered at all).
The Results domain meanwhile aims at evaluating the quality and
suitability of the results and analyses, and again a score of 10 was
TABLE 1 | The four initial in vivo and in vitro neuroscience protocols selected for
the PEERS platform.
In vivo In vitro
Open Field Western blotting
Water Maze PCR
EEG ELISA
Conditioned Place Preference Calcium Imaging
awarded if all items were sufficiently addressed. The scorecards
constitute a unique feature of the PEERS database because not
only do they evaluate reporting of the methods in any paper, but
also take into account the suitability and strength of the results
presented. Table 2 provides a detailed depiction of the checklist
score utilized for the in vivo protocols.
Overall Grading of Evidence – The Extraction
As mentioned before, scorecards provide a possibility to
objectively evaluate and assess the strength of evidence that a
given factor may or may not impact a specific protocol. The
assessors/users are initially asked to select whether a particular
reference supports or negates the influence of a factor for a certain
protocol. After filling out the scorecards, the system will then
automatically calculate a score sum. If only one assessor has
scored a single reference, the score of this reference is presented.
Ideally, however, each reference is evaluated by two or more
assessors to remove any source of bias, and thus an average score
of all scorecards is presented, along with the calculated standard
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TABLE 2 | “Scorecard” checklist for the in vivo protocols.
Methods domain - Based on “Essential 10” of ARRIVE 2.0 Score (max 10)
Study design 1 For each experiment, are brief details of study design provided, including:
a. The groups being compared, including control groups? If no control group has been used, is the rationale stated?
b. The experimental unit (e.g., a single animal, litter, or cage of animals)?
min: 0 max: 1
Sample Size 2 (a) Are the exact number of experimental units allocated to each group, and the total number in each experiment
mentioned?
b. Is the sample size provided and the rationale for it?




3 a. Were all criteria used for including and excluding animals (or experimental units) during the experiment, and data points
during the analysis mentioned? Were these mentioned a priori and if not, was this stated in the paper?
b. If any animals or data points or experimental units were excluded, was this reported and explained?
c. For each analysis, was the exact value of n in each experimental group reported?
min: 0 max: 1
Randomization 4 a. Was randomization used to allocate experimental units to control and treatment groups? If done, was the method
mentioned?
b. Was the strategy used to minimize potential confounders such as the order of treatments and measurements, or
animal/cage location mentioned? If confounders were not controlled was this stated explicitly?
min: 0 max: 1
Blinding 5 Was blinding done during the allocation, the conduct of the experiment, the outcome assessment, and the data analysis
and if so how?
min: 0 max: 1
Outcome
measures
6 a. Have all outcome measures assessed been mentioned? (e.g., cell death, molecular markers, or behavioral changes)?
b. For hypothesis-testing studies, has the primary outcome measure, i.e., the outcome measure that was used to
determine the sample size been mentioned?
min: 0 max: 1
Statistical
methods
7 a. Have all details of the statistical methods used for each analysis, including software used been provided?
b. Were any methods used to assess whether the data met the assumptions of the statistical approach described, and
what was done if the assumptions were not met?
min: 0 max: 1
Experimental
animals
8 a. Were species-appropriate details of the animals used, including species, strain and substrain, sex, age or developmental
stage, and, if relevant, weight described?
(b) Was further relevant information on the provenance of animals, health/immune status, genetic modification status,
genotype, and any previous procedures etc., mentioned?
min: 0 max: 1
Experimental
procedures
9 For each experimental group, including controls, were experimental procedures mentioned in enough detail to allow others
to replicate them, including:
a. What was done, how it was done and what was used?
b. When and how often?
c. Where (including detail of any acclimatization periods)?
d. Why (provide rationale for procedures)?
min: 0 max: 1
Result 10 For each experiment conducted, including independent replications, were:
a. Summary/descriptive statistics for each experimental group, with a measure of variability where applicable (e.g., mean
and SD, or median and range) reported?
b. If applicable, was the effect size with a confidence interval mentioned?
min: 0 max: 1




1 How appropriate was the data and statistical analysis performed and reported in results? min: 0 max: 5
2 How appropriate and suitable were the conclusion and inferences made? min: 0 max: 5
deviation, standard error and confidence intervals around the
average score. This detailed information provides the user with a
better understanding of the degree of consensus that the assessors
reached evaluating the quality of the reference.
Besides the number of assessors for each reference, also the
number of identified references for each factor needs to be
considered when calculating the final score. When at least two
assessors have scored two references, the system automatically
starts a meta-analytic calculation process: based on previously
described equations (Neyeloff et al., 2012), a fixed-effect model
is used and I2 test statistics are applied to evaluate the
heterogenicity between assessors and references, thus testing both
the consensus of the assessors for each reference as well as
the consensus of the references regarding the factor of interest.
Moreover, forest plots are generated with confidence intervals
depicted, providing a bird’s eye view of all scores/scorecards
that exist in the PEERS database for a certain factor or a
certain protocol.
The grading system is then simplified to establish the overall
scores for each factor into high (>14/20), medium (5–13/20),
and low (<5/20) quality (or no evidence), which will then be
displayed for users on the front-end of the platform. For reasons
of transparency, all described information is freely accessible on
the PEERS platform.
Platform Users and Contributors
All first-time users of the PEERS platform need to register and
accept the PEERS Code of Conduct (CoC- see below in Section
“Proposed Curation Mechanisms and Community Engagement”)
in order to use PEERS. This includes a small profile page where
Frontiers in Behavioral Neuroscience | www.frontiersin.org 5 October 2021 | Volume 15 | Article 755812
fnbeh-15-755812 October 19, 2021 Time: 12:17 # 6
Sil et al. PEERS – Exchange of Experimental Standards
individual users will provide details of their present affiliation,
level of expertise and areas of interest. These users can be
from academia or from industry at any stage of their scientific
career such as early career researchers – Ph.D. students; research
assistants and fellows – as well as established researchers. This
also allows users to be guided to areas of interest that match
their profile. The platform will display the active users and
will also show details of their involvement and contribution to
different protocols (optional, only if desired). With time, these
measurable contributions/metrics can be utilized by PEERS users
to demonstrate their effort, time involvement and value.
Until a critical number of users is reached, the scoring
of publications by new (and unexperienced) users will be
moderated by experienced members of the PEERS Working
Group. This will ensure that data quality is verified and
moderated. However, as mentioned in Section “Checklist
for Grading of Evidence/Publications - The Evaluation”, the
scorecard checklists are kept as simple and intuitive as possible
(e.g., by adhering to the ARRIVE 2.0 guidelines for methods
reporting) so that scoring of publications is neither time-
consuming nor difficult.
Once registered, users can ask questions about the relevance
of specific factors by interacting with the “Data Search
Module” (Figure 2). Additionally, users can also contribute by
reviewing and scoring references using the “Data Input Module.”
Ultimately, PEERS extracts an output for the user summarizing
the “status” of the factor of interest and detailing the scientific
strength available that the factor may indeed influence the design,
conduct and reporting phase of the protocol of choice.
Description of the PEERS Prototype
The current PEERS prototype consists of a web application
such that any user, after registration, may insert data and
review any existing protocol datasets. The central entities to
be collected and stored in the PEERS database are the in vivo
and in vitro protocols including all related factors, references,
and scorecards. The prototype is set up using the popular
ReactJS library with a simple and effective design provided
by the Semantic UI framework. By implementing a relational
schema, provisions have been made for easy data transformation
using semi-structured formats such as JSON and XML, so
they are ready for sharing with other applications or systems
through an Application Programming Interface (API). The
prototype will also include a user management, authentication,
and authorization module so that the access/contributions of
each user can be tracked and presented in the final dataset.
This feature facilitates implementation of collaborative elements,
which PEERS seeks to integrate. The application will be accessible
using any web browser via the GPDF’s website.2
An Example: The “Open Field” Protocol
The following example demonstrates how the different back-
end functionalities of PEERS will translate into the front-end
“Extracted Output” displayed on the PEERS platform when users
2www.preclinicaldataforum.org
aim to retrieve information about specific factors for the Open
Field in vivo protocol (Figure 3).
Accessing the Open Field test for the first time, users of PEERS
might want to ask the question: “Do the factors ‘Sex’ (generic)
and ‘Illumination level of arena’ (specific) affect the outcome of the
Open Field test?”
a) As a first step, users accessing the platform can input their
query into the search module such as: Will the factor “Sex”
affect the outcome of an Open Field test? or Will the factor
“Illumination level of arena” affect the outcome of an Open
Field test? and click Search. All factors and tests will be
displayed in drop-down menus.
b) Subsequently, the PEERS database will (i) locate all the
factors pertaining to the Open Field protocol and will
select “Sex” or “Illumination level of arena” from these,
(ii) generate the list of references (via DOIs) for the two
factors, (iii) provide scorecards scored by reviewers for
each of the references, (iv) use the mathematical model
to resolve any discrepancies between reviewers/multiple
references, and (v) generate the overall extracted output of
the evidence for “Sex” or “Illumination level of Arena” as
either high (>14/20), medium (5–13/20), or low (<5/20)
quality (or no evidence).
c) The extracted output status of the two factors will then be
visualized as “HIGH” in this case - meaning that it is highly
likely that both factors “Sex” and “Illumination level of
arena” can affect the outcome of the Open Field paradigm.
To ensure full transparency, users will also have access to
all scorecards and related references for each of the papers
scored and can follow each step to understand how the
overall grading of evidence was achieved.
FUTURE DIRECTIONS AND OUTLOOK
Proposed Curation Mechanisms and
Community Engagement
Wiki-Like Functionality
To involve the larger scientific community in building and
growing the PEERS database, a wiki-like functionality is adopted
to allow the collaborative modification and addition of content
and structure. The wiki concept ensures that all stakeholders
(including early career researchers – Ph.D. students; research
assistants and fellows – and established professionals) can actively
participate in the curation and reviewing process of evidence
pertaining to a protocol using a standardized approach to
evaluate the evidence. The presence of multiple reviewers for each
factor and protocol will ensure that there is no bias while the
meta-analysis approach described above will be utilized to resolve
any disagreement between reviewers and adjust the strength of
evidence should new information become available.
Editing, curating, and maintaining the PEERS platform
is integral to the process and the Working Group is
proposing several measures to credit any contributor to the
review/editing/curating process. Some of these proposals include
making PEERS recommendations citable like conventional
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FIGURE 3 | The “Open Field” protocol example, demonstrating how the different back-end functionalities of PEERS will translate into the “Extracted Output,”
presented to PEERS users. A search query for a specific factor/protocol will lead to the selection of all relevant references from the PEERS database dealing with the
factor of interest (e.g., the “illumination level of the arena”). Based on the scorecards for these references the combined score is calculated which translates into the
overall extracted output for the selected factor/protocol combination. This status is then presented to the user. Users also have access to all scorecards to
understand how the overall grading of evidence was achieved.
publications or developing the platform such that contributors’
names appear on protocols they have contributed to. In
addition to voluntary contributions, qualified staff will
ensure maintenance, quality management of the content
on the database, sustainability and project management
functionalities where needed.
Governance: The PEERS Code of Conduct
The PEERS platform aims to be a community-driven resource
which will be curated and updated regularly in an open fashion.
We expect biomedical researchers from both academia and
industry all over the world to become members and contributors
of this community. Above all, we would expect this community
to be respectful and engaging to ensure that we reach a broader
audience and be helpful to scientists at different stages of
their career and in different research environments. Therefore,
we will implement a PEERS Code of Conduct (CoC) and all
users will have to accept the PEERS CoC before becoming
contributors or active users. The CoC will be formulated as a
guide to make the community-driven nature of the platform
productive and welcoming.
However, violations of the CoC will affect the user’s ability to
contribute to the PEERS database and to score papers and engage
with the wider PEERS community. Often users will be scoring the
quality of methods and results presented in a scientific paper and
these are bound to have consequences for other users, colleagues
or authors of that paper and therefore, it is important to be
respectful, fair and open. Users must not allow their personal
prejudices or preferences to overshadow the scoring of any papers
and must judge a paper purely on the content presented in it.
Disagreements should be dealt with in a professional manner
and when possible, informally. However, if the informal processes
prove inadequate to resolve conflicts, PEERS will establish a
structured procedure to deal with any complaints or report
against any problematic users. The full CoC will be placed on the
platform when it goes live.
Community Engagement
In order to measure community engagement directly during
the testing and validation phase of the platform, the so-called
“Voice of the Customer” approach was and will be utilized.
This is one of the most popular Agile techniques to capture
product functionality as well as user needs and connects the
PEERS platform directly with those who are likely to engage
with it while also taking their valuable feedback on board.
We aim to do this in various ways: (i) obtain user feedback
following the product launch via succinct surveys and offer them
an attractive opportunity to beta-test new protocols prior to
release on the platform; (ii) interview users about their research
problems, how they address them and how PEERS could aid their
requirements; (iii) listen to users and implement new features and
functionalities to the PEERS platform. This approach will help to
identify the most vital protocols and facilitate the development of
PEERS together with the user and maximize its usefulness. Initial
feedback from end user interviews and a small survey suggests
a willingness not only to use the PEERS platform to search for
information but indeed also to act as a contributor to complete
and update any relevant protocols.
Finally, PEERS will establish its presence via social media
websites (e.g., Researchgate, Twitter, LinkedIn, and others) to
update the scientific community regularly on new developments
and to recruit reviewers for newly added protocols via “call-
to-action” announcements. Other indirect metrics to ensure the
uptake and adoption of PEERS by the wider scientific community
Frontiers in Behavioral Neuroscience | www.frontiersin.org 7 October 2021 | Volume 15 | Article 755812
fnbeh-15-755812 October 19, 2021 Time: 12:17 # 8
Sil et al. PEERS – Exchange of Experimental Standards
and measure success will employ popular mechanisms utilized
by online publications such as the number of hits, user access
for each protocol and factor, the number of downloads of the
evidence related to each factor and the number of downloads
for the cited publications. Information will be graphically
displayed on the platform and updated instantly. We will use
this approach to identify (a) popular protocols; (b) protocols
with low engagement; (c) popular modes of engagement with
the different protocols. Outcomes will identify areas of global
interest for researchers who use the platform. Simultaneously,
this information enables us to identify specific knowledge gaps
and we will seek to close them.
Long-Term Vision of PEERS
At present, given the short period of its existence, contents of
the database are limited, but PEERS aims to upscale and expand
by constantly adding new protocols. Given the composition of
the Working Group, the list of protocols will be expanded to
include other commonly employed, as well as newly developed
neuroscience methods such as in vivo/in vitro electrophysiology,
cell culture (2D + 3D), optogenetics, elevated plus maze,
qPCR, flow cytometry, light-dark box, conditioned fear etc. The
database will continue to be curated and updated for already
published protocols.
In the longer term, PEERS aims to attract a broader user
base and therefore, the ambition is to branch out and include
protocols from other biological disciplines such as infection,
inflammation, immunity, cardiovascular sciences, microbial
research, etc. Furthermore, the inclusion of expert unpublished
data and information related to the importance of specific factors
may also be warranted. However, strict rules would need to be set
out to ensure proper management, quality control and utility of
such unpublished data.
As one of the next steps to aid this expansion, we seek to
establish a “Board of Editors” of PEERS akin to an editorial
board of a scientific journal, in which all biological disciplines
will be represented. Novel protocols can be commissioned
accordingly, and the wiki-like structure of the platform would
then persist with the Board of Editors reviewing contributions
to ensure the extraction of evidence for specific factors is
appropriate. The members of the Board of Editors alongside the
contributors will be displayed on the platform to make everyone’s
contribution transparent.
Most importantly, as PEERS does not compete with existing
initiatives for the reporting of results or with guidelines for
scientific conduct, we envisage interactions with initiatives such
as ARRIVE, EQIPD, FAIR and others to be fruitful in increasing
the quality and reproducibility of research in the future.
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